Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes

被引：52

作者：

Doll, MA ^{[1
]}

Hein, DW ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA

来源：

ANALYTICAL BIOCHEMISTRY | 2001年 / 288卷 / 01期

关键词：

D O I：

10.1006/abio.2000.4892

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：106 / 108

页数：3

共 19 条

[1] GENOTYPE-PHENOTYPE DISCORDANCE FOR HUMAN ARYLAMINE N-ACETYLTRANSFERASE (NAT2) REVEALS A NEW SLOW-ACETYLATOR ALLELE COMMON IN AFRICAN-AMERICANS
BELL, DA
TAYLOR, JA
BUTLER, MA
STEPHENS, EA
WIEST, J
BRUBAKER, LH
KADLUBAR, FF
LUCIER, GW
[J]. CARCINOGENESIS, 1993, 14 (08) : 1689 - 1692
[2] Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay
Bigler, J
Chen, C
Potter, JD
[J]. BIOTECHNIQUES, 1997, 22 (04) : 682 - &
[3] Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes
Blömeke, B
Sieben, S
Spötter, D
Landt, O
Merk, HF
[J]. ANALYTICAL BIOCHEMISTRY, 1999, 275 (01) : 93 - 97
[4] MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS
BLUM, M
DEMIERRE, A
GRANT, DM
HEIM, M
MEYER, UA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) : 5237 - 5241
[5] CASCORBI I, 1995, AM J HUM GENET, V57, P581
[6] Deitz AC, 2000, CANCER EPIDEM BIOMAR, V9, P905
[7] DETERMINATION OF HUMAN NAT2 ACETYLATOR GENOTYPE BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND ALLELE-SPECIFIC AMPLIFICATION
DOLL, MA
FRETLAND, AJ
DEITZ, AC
HEIN, DW
[J]. ANALYTICAL BIOCHEMISTRY, 1995, 231 (02) : 413 - 420
[8] Pharmacogenomics: Translating functional genomics into rational therapeutics
Evans, WE
Relling, MV
[J]. SCIENCE, 1999, 286 (5439) : 487 - 491
[9] Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29
[10] ACETYLATOR GENOTYPE AND ARYLAMINE-INDUCED CARCINOGENESIS
HEIN, DW
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) : 37 - 66

← 1 2 →